- Home
- BZFD vs ANL Comparison
BZFD vs ANL Comparison
Compare BZFD & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZFD
- ANL
- Stock Information
- Founded
- BZFD 2006
- ANL 2004
- Country
- BZFD United States
- ANL Cayman Islands
- Employees
- BZFD N/A
- ANL N/A
- Industry
- BZFD Movies/Entertainment
- ANL
- Sector
- BZFD Consumer Discretionary
- ANL
- Exchange
- BZFD Nasdaq
- ANL Nasdaq
- Market Cap
- BZFD 76.3M
- ANL 61.8M
- IPO Year
- BZFD N/A
- ANL 2023
- Fundamental
- Price
- BZFD $1.88
- ANL $1.79
- Analyst Decision
- BZFD
- ANL Hold
- Analyst Count
- BZFD 0
- ANL 1
- Target Price
- BZFD N/A
- ANL N/A
- AVG Volume (30 Days)
- BZFD 218.5K
- ANL 9.3K
- Earning Date
- BZFD 11-11-2025
- ANL 09-26-2025
- Dividend Yield
- BZFD N/A
- ANL N/A
- EPS Growth
- BZFD N/A
- ANL N/A
- EPS
- BZFD 0.25
- ANL N/A
- Revenue
- BZFD $194,178,000.00
- ANL N/A
- Revenue This Year
- BZFD $6.87
- ANL N/A
- Revenue Next Year
- BZFD $6.21
- ANL N/A
- P/E Ratio
- BZFD $7.46
- ANL N/A
- Revenue Growth
- BZFD 1.38
- ANL N/A
- 52 Week Low
- BZFD $1.61
- ANL $1.10
- 52 Week High
- BZFD $5.68
- ANL $3.89
- Technical
- Relative Strength Index (RSI)
- BZFD 42.49
- ANL 60.57
- Support Level
- BZFD $1.86
- ANL $1.65
- Resistance Level
- BZFD $2.08
- ANL $1.91
- Average True Range (ATR)
- BZFD 0.10
- ANL 0.10
- MACD
- BZFD 0.01
- ANL 0.00
- Stochastic Oscillator
- BZFD 25.93
- ANL 58.02
About BZFD BuzzFeed Inc.
BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.